BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 33731932)

  • 1. DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation.
    Hollingsworth LR; Sharif H; Griswold AR; Fontana P; Mintseris J; Dagbay KB; Paulo JA; Gygi SP; Bachovchin DA; Wu H
    Nature; 2021 Apr; 592(7856):778-783. PubMed ID: 33731932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment.
    Sharif H; Hollingsworth LR; Griswold AR; Hsiao JC; Wang Q; Bachovchin DA; Wu H
    Immunity; 2021 Jul; 54(7):1392-1404.e10. PubMed ID: 34019797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding.
    Zhong FL; Robinson K; Teo DET; Tan KY; Lim C; Harapas CR; Yu CH; Xie WH; Sobota RM; Au VB; Hopkins R; D'Osualdo A; Reed JC; Connolly JE; Masters SL; Reversade B
    J Biol Chem; 2018 Dec; 293(49):18864-18878. PubMed ID: 30291141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biochemical mechanisms of NLRP1 inhibition by DPP9.
    Huang M; Zhang X; Toh GA; Gong Q; Wang J; Han Z; Wu B; Zhong F; Chai J
    Nature; 2021 Apr; 592(7856):773-777. PubMed ID: 33731929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammasome sensor NLRP1 disease variant M1184V promotes autoproteolysis and DPP9 complex formation by stabilizing the FIIND domain.
    Moecking J; Laohamonthonkul P; Meşe K; Hagelueken G; Steiner A; Harapas CR; Sandow JJ; Graves JD; Masters SL; Geyer M
    J Biol Chem; 2022 Dec; 298(12):102645. PubMed ID: 36309085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPP9's Enzymatic Activity and Not Its Binding to CARD8 Inhibits Inflammasome Activation.
    Griswold AR; Ball DP; Bhattacharjee A; Chui AJ; Rao SD; Taabazuing CY; Bachovchin DA
    ACS Chem Biol; 2019 Nov; 14(11):2424-2429. PubMed ID: 31525884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the CARD8 Inflammasome Requires a Disordered Region.
    Chui AJ; Griswold AR; Taabazuing CY; Orth EL; Gai K; Rao SD; Ball DP; Hsiao JC; Bachovchin DA
    Cell Rep; 2020 Oct; 33(2):108264. PubMed ID: 33053349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DPP8/DPP9 inhibition elicits canonical Nlrp1b inflammasome hallmarks in murine macrophages.
    de Vasconcelos NM; Vliegen G; Gonçalves A; De Hert E; Martín-Pérez R; Van Opdenbosch N; Jallapally A; Geiss-Friedlander R; Lambeir AM; Augustyns K; Van Der Veken P; De Meester I; Lamkanfi M
    Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30718379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KSHV-encoded ORF45 activates human NLRP1 inflammasome.
    Yang X; Zhou J; Liu C; Qu Y; Wang W; Xiao MZX; Zhu F; Liu Z; Liang Q
    Nat Immunol; 2022 Jun; 23(6):916-926. PubMed ID: 35618833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling.
    Harapas CR; Robinson KS; Lay K; Wong J; Moreno Traspas R; Nabavizadeh N; Rass-Rothschild A; Boisson B; Drutman SB; Laohamonthonkul P; Bonner D; Xiong JR; Gorrell MD; Davidson S; Yu CH; Fleming MD; Gudera J; Stein J; Ben-Harosh M; Groopman E; Shimamura A; Tamary H; Kayserili H; Hatipoğlu N; Casanova JL; Bernstein JA; Zhong FL; Masters SL; Reversade B
    Sci Immunol; 2022 Sep; 7(75):eabi4611. PubMed ID: 36112693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity.
    Moecking J; Laohamonthonkul P; Chalker K; White MJ; Harapas CR; Yu CH; Davidson S; Hrovat-Schaale K; Hu D; Eng C; Huntsman S; Calleja DJ; Horvat JC; Hansbro PM; O'Donoghue RJJ; Ting JP; Burchard EG; Geyer M; Gerlic M; Masters SL
    J Allergy Clin Immunol; 2021 Jun; 147(6):2134-2145.e20. PubMed ID: 33378691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein folding stress potentiates NLRP1 and CARD8 inflammasome activation.
    Orth-He EL; Huang HC; Rao SD; Wang Q; Chen Q; O'Mara CM; Chui AJ; Saoi M; Griswold AR; Bhattacharjee A; Ball DP; Cross JR; Bachovchin DA
    Cell Rep; 2023 Jan; 42(1):111965. PubMed ID: 36649711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DPP8/9 inhibitors are universal activators of functional NLRP1 alleles.
    Gai K; Okondo MC; Rao SD; Chui AJ; Ball DP; Johnson DC; Bachovchin DA
    Cell Death Dis; 2019 Aug; 10(8):587. PubMed ID: 31383852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of filament formation in UPA-promoted CARD8 and NLRP1 inflammasomes.
    Robert Hollingsworth L; David L; Li Y; Griswold AR; Ruan J; Sharif H; Fontana P; Orth-He EL; Fu TM; Bachovchin DA; Wu H
    Nat Commun; 2021 Jan; 12(1):189. PubMed ID: 33420033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NLRP1 and CARD8 inflammasomes.
    Taabazuing CY; Griswold AR; Bachovchin DA
    Immunol Rev; 2020 Sep; 297(1):13-25. PubMed ID: 32558991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophagocytic lymphohistiocytosis-like hyperinflammation due to a de novo mutation in DPP9.
    Wolf C; Fischer H; Kühl JS; Koss S; Jamra RA; Starke S; Schultz J; Ehl S; Neumann K; Schuetz C; Huber R; Hornung V; Lee-Kirsch MA
    J Allergy Clin Immunol; 2023 Nov; 152(5):1336-1344.e5. PubMed ID: 37544411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DPP9 restrains NLRP1 activation.
    Bauernfried S; Hornung V
    Nat Struct Mol Biol; 2021 Apr; 28(4):333-336. PubMed ID: 33785922
    [No Abstract]   [Full Text] [Related]  

  • 18. M24B aminopeptidase inhibitors selectively activate the CARD8 inflammasome.
    Rao SD; Chen Q; Wang Q; Orth-He EL; Saoi M; Griswold AR; Bhattacharjee A; Ball DP; Huang HC; Chui AJ; Covelli DJ; You S; Cross JR; Bachovchin DA
    Nat Chem Biol; 2022 May; 18(5):565-574. PubMed ID: 35165443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ubiquitin-independent proteasome pathway controls activation of the CARD8 inflammasome.
    Hsiao JC; Neugroschl AR; Chui AJ; Taabazuing CY; Griswold AR; Wang Q; Huang HC; Orth-He EL; Ball DP; Hiotis G; Bachovchin DA
    J Biol Chem; 2022 Jul; 298(7):102032. PubMed ID: 35580636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia.
    Johnson DC; Taabazuing CY; Okondo MC; Chui AJ; Rao SD; Brown FC; Reed C; Peguero E; de Stanchina E; Kentsis A; Bachovchin DA
    Nat Med; 2018 Aug; 24(8):1151-1156. PubMed ID: 29967349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.